🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Honoured and humbled to be promoted to Professor. Reflection of the brilliant contributions of the many scientists and trainees Roychoudhuri Lab and our collaborators over the years, and the kindness and support of colleagues @CamPathology School of Biological Sciences and St Catharine's College

Our lab's latest paper on peripheral tolerance mechanisms in skin is out now in nature. Congrats to Martina Damo for leading this and thanks to collaborators from Krishnaswamy Lab and Yale Dermatology. nature.com/articles/s4158…

V. Happy to share recent work from the lab, led by Lloyd Bod on Tim-1 expressing B cells in cancer: nature.com/articles/s4158… Many thanks to all co-authors and collaborators who contributed over the years!

Ever considered moving your lab? It is not a trivial exercise. If it could be on your horizons, take a look at our #ImmunologyFutures article in ICB - the journal on when to start planning and what to expect at the different stages. #AcademicCareers onlinelibrary.wiley.com/doi/10.1111/im…

We have a post-doc position available focused on intestinal and cancer immunology. Ideal for PhD students soon to submit, who want to work with some cool in vivo models to better understand immune responses. Position advertised on BSI Jobs Board immunology.org/careers/bsi-jo…

Thrilled to see our paper published nature. nature.com/articles/s4158… This is a great teamwork with James Cranley who is my master of human heart! Happy to be as a member of Teichlab, and thank you to Sarah, Michela Noseda, and everyone who is around us.

New study led by Lina Petersone now in Journal of Experimental Medicine . Cytokine IL-21 from Tfh promotes germinal center (GC) responses & is overproduced in #autoimmune diseases. We found IL-21R deficiency led to a GC dark zone defect in autoimmune and immunisation settings 1/4 doi.org/10.1084/jem.20…

Excited for our most recent manuscript to be out in the wild.

Our recent findings on the role of the RNA binding protein ZFP36l1 in establishing rules for competition between T cells have now been published. #Tcells #IL2 #affinity #selection #RNAbindingproteins #BabrahamInst onlinelibrary.wiley.com/doi/abs/10.100…

Interested in a #postdoc in #neuroimmunology at Cambridge University? We have a translational position open to develop #genetherapy for #traumaticbraininjury, with potential to transition into a spin-off company, Aila Biotech. jobs.cam.ac.uk/job/44372/

Our Bridge to Academic Leadership programme kicked off this week with our first in-person session! Over the next six months, this exceptional group of postdocs will develop the skills they need to succeed as independent group leaders.

📢We're recruiting! Please RT. Fully funded PhD project starting Oct 2025. Interested in #mechanobiology #CancerResearch #Immunology? Awesome project w/ Leone Rossetti & Eileen Gentleman Lab studying the impact of tissue mechanics on T-cells 📷 kcl.ac.uk/dentistry/rese……. Deadline 19 Jan

Thrilled to share new work led by Jie Yang in the lab published today in nature. We find that Aspirin prevents metastasis by releasing T cells from immune suppression by platelet TXA2. Cambridge University CRUK Cambridge Centre rdcu.be/eci1U

Thank you for covering our work

Thank you for your help and support, Suman.

If this holds in clinical trials, it could revolutionize cancer treatment and make it so much more accessible! Incredible finding 👏

#ScienceSaturday ❓ Can a common pain reliever help fight cancer? ➡️ Aspirin is known for its heart health benefits, but new research suggests it might also help in reducing cancer metastasis. ➡️ In this study, Jie Yang, et al. found low-dose aspirin (75–300 mg) inhibits

Thanks, Carly.

"An aspirin a day keeps cancer at bay" - Read the comment in #BJCReports on a recent study by Jie Yang et al. nature.com/articles/s4427…